CClinicalTrials.gg
Status unknownNCT004914654301Updated Jun 26, 2007

The Role of Physical Activity in the Treatment of Children With Type 1 Diabetes.

An interventional study of Intensive Physical activity and Control- regular physical activity in Type 1 Diabetes, sponsored by Rabin Medical Center. Status unknown at 1 site in Israel. Open to participants aged 8 Years to 16 Years. Per ClinicalTrials.gov, last updated 2007-06-26.

Sponsored by Rabin Medical Center · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Jun 2007), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
2,007
Allocation
Randomized
Ages
8 Years to 16 Years
Sex
All
01

Study summary

Randomized, controlled, open, comparative intervention study in two groups, each consisting of 25 children with type 1 diabetes that will undergo twelve weeks of exercise program (intensive arm) and twelve weeks of regular activity (non intensive arm) separated by four week of washout period. The study will be conducted in a crossover manner: one group starting with the intensive arm followed by the non intensive arm and vice versa. Blood glucose, HbA1C, Fructosamine, 3 days continuous glucose monitoring system (CGMS), total daily insulin dose, fasting lipid profile, body impedance and BMR will be measured. Self esteem and quality of life questionnaires will be filled.

Read the detailed description

Randomized, controlled, open, comparative, cross-over, intervention study in 50 children with type 1 diabetes.

objectives:

Primary objective To evaluate the efficacy and safety of physical activity for metabolic control in children with type I diabetes.

Secondary objectives

  1. To characterize the severity and pattern of occurrence of hypo and hyperglycemic episodes during and after exercise program in type I diabetic children.
  2. To evaluate changes in insulin sensitivity during and after periods of exercise in type I diabetic children.
  3. To evaluate the short term effect of exercise on BMI and body composition in type I diabetic children.
  4. To evaluate the short term effect of exercise on lipid profile in type I diabetic children.
  5. To evaluate differences in self esteem and quality of life between exercising and non exercising type I diabetic children.

Randomization:

Children will be randomly allocated into two groups of 25.The study will be conducted in a crossover manner:one group starting with the intensive arm followed by the non intensive arm and vice versa.

methods:

  1. The study will have an intensive arm and a non intensive arm, each lasting 12 weeks.
  2. Children fulfilling the inclusion and exclusion criteria will be randomly assigned to two groups. Each group will include 25 patients.
  3. Participants will fill questionnaires regarding physical activity.
  4. The first group will start with the intensive arm, followed by one month washout, and then the non intensive arm.
  5. The second group will start the study with the non intensive arm, followed by one month washout and then the intensive arm .
  6. The intensive arm will consist of an exercise program which will include high intensity progressive exercise (75% maximum age adjusted heart rate HRmax) 3 days a week for 90 minutes. The 90 min exercise will be a combination of aerobic exercise 45min. and resistance exercise 45 min.
  7. The exercise program will be planned and carried out by professional sports instructors.
  8. During the non intensive arm the participants will resume regular daily activity. They will keep records of their weekly physical activity and will get a weekly phone call from the treating doctor, addressing specifically physical activity performed during the past week and glucose levels before and after exercise.
  9. The following parameters will be measured for both groups at the beginning and the end of the intensive and non intensive arm and once again 12 weeks afterwards : Weight, height, pulse, blood pressure, waist circumference, skin folds, HbA1C , fructosamine ,3 days CGMS +3 day SBGM profile (will be measured to 40% of participants chosen randomly) ,total daily insulin dose ,blood sample for fasting lipid profile ,Body impedance and BMR , self esteem and quality of life questionnaires .
  10. Study participants will be required to measure blood glucose by glucometer at least 4 times a day and to record hypo and hyperglycemic events and their severity.

15.Both children and investigators will be blinded to CGMS results. 16.During the 3 day CGMS recording, the children's parents will be asked to monitor SBGM once during the night (in the intensive arm, following the exercise day).

02

Conditions studied

  • Type 1 Diabetes

Keywords

  • Type 1 Diabetes, physical activity, pediatric, metabolic control
03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's planned enrollment of 2,007 is above the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Rabin Medical Center is the lead sponsor of 385 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Type I diabetic children
  2. Tanner stage II-IV
  3. Patients of the Schneider's national institute of childhood diabetes. Duration of diabetes
  4. more than one year.
  5. HbA1C between 8 and 12 at time 0.
  6. Mandatory 4 daily self blood glucose measurements and daily recording of adverse events.
  7. A signed informed consent of the parents and child.

Exclusion criteria

Exclusion Criteria:

  1. Additional chronic significant disease such as cardiac, liver, renal disease .
  2. Children who exercise regularly more than 180 min per week.
  3. Cardiac symptoms: history of chest pain , syncope , palpitations or dyspnea during exercise.
  4. Eating disorders.
  5. Participation in a study during the past month.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
2,007 participants (estimated)

Interventions

  • BehavioralIntensive Physical activity
  • BehavioralControl- regular physical activity
06

What researchers measure

Primary outcomes

  1. HbA1C

    Time frame: 0,3 monthes

  2. fructosamine

    Time frame: 0,3 monthes

Secondary outcomes

  1. Body composition & BMR

    Time frame: 0,3 monthes

  2. Self esteem & QOL questionnaires

    Time frame: o, 3 monthes

  3. 3 days CGMS & SBGM profile

    Time frame: 0,3 monthes

07

Study locations

1 site
  • Schnider children's medical center
    Petach-Tikva, Israel
    • Ravital Nimri, MD · Principal investigator
    • Moshe Phillip, Prof. · Principal investigator
    • Rachel Frumkin, MD · Sub investigator
    • Neomi Weintrob, MD · Sub investigator
    • Shlomit Shalitin, MD · Sub investigator
    • Nesia Nagelberg, MA · Sub investigator
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 26, 2007, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00491465
Lead sponsor
Rabin Medical Center
First posted
Jun 26, 2007
Start date
Jul 2007
Completion
Jul 2009 (estimated)
Last update
Jun 26, 2007

Study contacts

Ravital Nimri, MD
Contact
ravitaln@clalit.org.il
972-39253778 ext. direct
Ravital Nimri, MD
principal investigator · Rabin Medical Center
Moshe Phillip, Prof
principal investigator · Rabin Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2007. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion